|
|
KLC3 |
kinesin light chain 3 |
- MHC class II antigen presentation
- RHO GTPases activate KTN1
- COPI-dependent Golgi-to-ER retrograde traffic
- Kinesins
|
|
|
|
|
KLC4 |
kinesin light chain 4 |
- MHC class II antigen presentation
- RHO GTPases activate KTN1
- COPI-dependent Golgi-to-ER retrograde traffic
- Kinesins
|
|
|
|
|
KRAS |
KRAS proto-oncogene, GTPase |
- Signaling by moderate kinase activity BRAF mutants
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- RUNX3 regulates p14-ARF
- RAS processing
- RAS GTPase cycle mutants
- Signaling downstream of RAS mutants
|
- [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID
- Farnesyl diphosphate
- MRTX849
- AMG-510
|
- Craniosynostosis, including: Pfeiffer syndrome; Apert syndrome; Crouzon syndrome; Jackson-Weiss syndrome; Beare-Stevenson syndrome; Muenke craniosynostosis; Saethre-Chotzen syndrome; Craniosynostosis Boston type; Antley-Bixler syndrome; Carpenter syndrome; Craniofrontonasal dysplasia; Noonan syndrome; Baller-Gerold syndrome
- Pancreatic cancer
- Gastric cancer
- Colorectal cancer
- Non-small cell lung cancer
- Noonan syndrome and related disorders, including: Noonan syndrome (NS); Leopard syndrome (LS); Noonan syndrome-like with loose anagen hair (NS/LAH); CBL-mutation associated syndrome (CBL); Neurofibromatosis type 1 (NF1); Neurofibromatosis type 2 (NF2); Neurofibromatosis-Noonan syndrome (NFNS); Legius syndrome; Cardiofaciocutaneous syndrome (CFCS); Costello syndrome (CS)
- Oral cancer
- Acute myeloid leukemia (AML)
- Endometrial Cancer
- Multiple myeloma
- Squamous cell carcinoma
- Kaposi's sarcoma
- Cholangiocarcinoma
- Thyroid cancer
- Cervical cancer
- Hepatocellular carcinoma
- Ovarian cancer
- Gallbladder cancer
|
|
|
KRT18 |
keratin 18 |
- Keratinization
- Formation of the cornified envelope
|
|
|
|
|
KRT31 |
keratin 31 |
- Keratinization
- Formation of the cornified envelope
|
|
|
|
|
LAMTOR3 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 |
- Macroautophagy
- MTOR signalling
- mTORC1-mediated signalling
- Energy dependent regulation of mTOR by LKB1-AMPK
- TP53 Regulates Metabolic Genes
- MAP2K and MAPK activation
- Neutrophil degranulation
- Regulation of PTEN gene transcription
- Amino acids regulate mTORC1
|
|
|
|
|
LENG1 |
leukocyte receptor cluster member 1 |
|
|
|
|
|
LIN37 |
lin-37 DREAM MuvB core complex component |
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
- G0 and Early G1
- Polo-like kinase mediated events
- Cyclin E associated events during G1/S transition
- G1/S-Specific Transcription
- Cyclin A:Cdk2-associated events at S phase entry
|
|
|
|
|
LMO4 |
LIM domain only 4 |
|
|
|
|
|
MAPRE3 |
microtubule associated protein RP/EB family member 3 |
|
|
|
|
|
MIF4GD |
MIF4G domain containing |
|
|
|
|
|
MTUS2 |
microtubule associated scaffold protein 2 |
|
|
|
|
|
MYBPC2 |
myosin binding protein C2 |
- Striated Muscle Contraction
|
|
|
|
|
MYOM1 |
myomesin 1 |
|
|
|
|
|
NAA10 |
N-alpha-acetyltransferase 10, NatA catalytic subunit |
|
|
|
|
|
NEFL |
neurofilament light |
- Unblocking of NMDA receptors, glutamate binding and activation
- Unblocking of NMDA receptors, glutamate binding and activation
- Ras activation upon Ca2+ influx through NMDA receptor
- RAF/MAP kinase cascade
- Assembly and cell surface presentation of NMDA receptors
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Long-term potentiation
|
|
- Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
|
|
|
NEK2 |
NIMA related kinase 2 |
- APC-Cdc20 mediated degradation of Nek2A
- Regulation of PLK1 Activity at G2/M Transition
- Loss of Nlp from mitotic centrosomes
- Recruitment of mitotic centrosome proteins and complexes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Recruitment of NuMA to mitotic centrosomes
- Anchoring of the basal body to the plasma membrane
- AURKA Activation by TPX2
|
- 5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide
- Fostamatinib
|
|
|
|
OSGEP |
O-sialoglycoprotein endopeptidase |
- tRNA modification in the nucleus and cytosol
|
|
|
|
|
PDE4D |
phosphodiesterase 4D |
- DARPP-32 events
- G alpha (s) signalling events
|
- Adenosine phosphate
- Caffeine
- Caffeine
- Dyphylline
- Iloprost
- Amrinone
- Roflumilast
- Piclamilast
- Rolipram
- 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
- 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol
- Zardaverine
- 1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
- (S)-Rolipram
- Cilomilast
- (R)-Rolipram
- 3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
- 1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
- Crisaborole
- Ibudilast
- Tetomilast
- Exisulind
- (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one
- 3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
- 3-isobutyl-1-methyl-7H-xanthine
- 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid
- Trapidil
|
|
|
|
PEA15 |
proliferation and apoptosis adaptor protein 15 |
- RAF-independent MAPK1/3 activation
- RAF/MAP kinase cascade
|
|
|